Related Experiment Video
Updated: May 21, 2026

CRISPR Gene Editing Tool for MicroRNA Cluster Network Analysis
Published on: April 25, 2022
Combinatorial network of transcriptional regulation and microRNA regulation in human cancer
1Key Lab of Systems Biology, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, Shanghai, People's Republic of China.
Background:
Both transcriptional control and microRNA (miRNA) control are critical regulatory mechanisms for cells to direct their destinies. At present, the combinatorial regulatory network composed of transcriptional regulations and post-transcriptional regulations is often constructed through a forward engineering strategy that is based solely on searching of transcriptional factor binding sites or miRNA seed regions in the putative target sequences. If the reverse engineering strategy is integrated with the forward engineering strategy, a more accurate and more specific combinatorial regulatory network will be obtained.
Results:
In this work, utilizing both sequence-matching information and parallel expression datasets of miRNAs and mRNAs, we integrated forward engineering with reverse engineering strategies and as a result built a hypothetical combinatorial gene regulatory network in human cancer. The credibility of the regulatory relationships in the network was validated by random permutation procedures and supported by authoritative experimental evidence-based databases. The global and local architecture properties of the combinatorial regulatory network were explored, and the most important tumor-regulating miRNAs and TFs were highlighted from a topological point of view.
Conclusions:
By integrating the forward engineering and reverse engineering strategies, we manage to sketch a genome-scale combinatorial gene regulatory network in human cancer, which includes transcriptional regulations and miRNA regulations, allowing systematic study of cancer gene regulation. Our work establishes a pipeline that can be extended to reveal conditional combinatorial regulatory landscapes correlating to specific cellular contexts.
Insights
This study integrates forward and reverse engineering to build a comprehensive gene regulatory network in human cancer. This network combines transcriptional and microRNA regulation for a more accurate understanding of cancer gene control.
Area of Science:
- Systems Biology
- Genomics
- Bioinformatics
Background:
- Transcriptional and microRNA (miRNA) control are essential cellular regulatory mechanisms.
- Current methods for constructing regulatory networks often rely on limited forward engineering strategies.
- Integrating reverse engineering with forward engineering can yield more accurate and specific combinatorial regulatory networks.
Purpose of the Study:
- To develop a genome-scale combinatorial gene regulatory network for human cancer.
- To integrate both transcriptional and miRNA regulations within this network.
- To enable systematic study of gene regulation in cancer.
Main Methods:
- Utilized sequence-matching information and parallel expression datasets of miRNAs and mRNAs.
- Integrated forward and reverse engineering strategies.
- Validated regulatory relationships using random permutation and experimental databases.
Main Results:
- Constructed a hypothetical combinatorial gene regulatory network in human cancer.
- Explored the global and local architecture of the network.
- Identified key tumor-regulating miRNAs and transcription factors (TFs) based on topological analysis.
Conclusions:
- Successfully integrated forward and reverse engineering to create a genome-scale combinatorial gene regulatory network for human cancer.
- The developed network includes both transcriptional and miRNA regulations, facilitating systematic cancer gene regulation studies.
- Established a pipeline extendable to reveal context-specific combinatorial regulatory landscapes.
Related Concept Videos
MicroRNAs
MicroRNAs
MicroRNAs
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Master Transcription Regulators

